NGM Biopharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
NGM Biopharmaceuticals Inc
CIK #0001426332
EDGAR Form CIK 2011 - 2026
10-K [0001426332]
10-Q [0001426332]
3 [0001426332]
4 [0001426332]
8-K [0001426332]
D [0001426332]
SC 13D [0001426332]
SC 13G [0001426332]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Group Inc NGM Biopharmaceuticals Inc [2023-02-09]
BlackRock Inc NGM Biopharmaceuticals Inc [2023-02-03]
EcoR1 Capital LLC NGM Biopharmaceuticals Inc [2022-10-28]
Rho Ventures V LP NGM Biopharmaceuticals Inc [2020-02-11]
Topspin Fund LP NGM Biopharmaceuticals Inc [2019-11-26]
Column Group L P NGM Biopharmaceuticals Inc [2019-04-12]
Merck & Co Inc NGM Biopharmaceuticals Inc [2019-04-09]
Form 3/4/5 Subject 2011 - 2026
NGM Biopharmaceuticals Inc
Viret Jean-Frederic
Woodhouse David J
TCG Opportunity III GP LLC
Column Group IV GP LP
Column Group III-A LP
Column Group GP LP
Column Group III GP LP
Column Group III LP
Column Group Opportunity III GP LP
Column Group Opportunity III LP
Column Group IV LP
TCG IV GP LLC
Column Group IV-A LP
Column Group II GP LP
Ponoi II Management LLC
Column Group II LP
Ponoi Management LLC
Svennilson Peter
Kutzkey Tim
Ponoi Capital LP
Ponoi Capital II LP
Column Group Management LP
Column Group L P
Goeddel David V
Lieu Hsiao D
Perlmutter Roger M
Rieflin William JL
Hooper Suzanne Sawochka
Guyer Shelly D
Ho Carole
Perlich Irene
Pierce Valerie L
Nolan Mangini Siobhan
Chen Jin-Long
Leschly Mark
Schnell David
Tichenor McHenry T
Trombley Aetna Wun
Merck & Co Inc
Merck Sharp & Dohme Corp
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
NGM Biopharmaceuticals Inc NGM
Common Stock
2024-04-05 Tender 7,000
NGM Biopharmaceuticals Inc NGM
Common Stock
2024-04-05 Disposed to issuer 11,103,333
NGM Biopharmaceuticals Inc NGM
Common Stock
2024-04-05 Disposed to issuer 11,103,333
NGM Biopharmaceuticals Inc NGM
Stock Option (Right to Buy) · derivative
2024-04-05 Disposed to issuer 147,000
NGM Biopharmaceuticals Inc NGM
Stock Option (Right to Buy) · derivative
2024-04-05 Disposed to issuer 255,000
NGM Biopharmaceuticals Inc NGM
Common Stock
2024-04-05 Disposed to issuer 11,103,333
NGM Biopharmaceuticals Inc NGM
Common Stock
2024-04-05 Tender 19,349
NGM Biopharmaceuticals Inc NGM
Stock Option (Right to Buy) · derivative
2024-04-05 Disposed to issuer 16,806
NGM Biopharmaceuticals Inc NGM
Stock Option (Right to Buy) · derivative
2024-04-05 Disposed to issuer 100,000
NGM Biopharmaceuticals Inc NGM
Common Stock
2024-04-05 Disposed to issuer 1,298,908
NGM Biopharmaceuticals Inc NGM
Common Stock
2024-04-05 Disposed to issuer 2,265,758
NGM Biopharmaceuticals Inc NGM
Common Stock
2024-04-05 Disposed to issuer 949,862
NGM Biopharmaceuticals Inc NGM
Common Stock
2024-04-05 Disposed to issuer 2,650,177
NGM Biopharmaceuticals Inc NGM
Common Stock
2024-04-05 Disposed to issuer 1,298,908
NGM Biopharmaceuticals Inc NGM
Stock Option (Right to Buy) · derivative
2024-04-05 Disposed to issuer 78,407
NGM Biopharmaceuticals Inc NGM
Common Stock
2024-04-05 Disposed to issuer 1,298,908
NGM Biopharmaceuticals Inc NGM
Stock Option (Right to Buy) · derivative
2024-04-05 Disposed to issuer 80,000
NGM Biopharmaceuticals Inc NGM
Common Stock
2024-04-05 Disposed to issuer 44,000
NGM Biopharmaceuticals Inc NGM
Common Stock
2024-04-05 Disposed to issuer 2,265,758
NGM Biopharmaceuticals Inc NGM
Common Stock
2024-04-05 Disposed to issuer 100,000
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com